Patterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
- Status
- COMPLETED
- Phase
- PHASE3
Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Korean Post-marketing Surveillance for Sprycel®
- Status
- COMPLETED
- Phase
- N/A
Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia
- Status
- COMPLETED
- Phase
- PHASE3
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma
- Status
- UNKNOWN
- Phase
- PHASE1
Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy
- Status
- WITHDRAWN
- Phase
- PHASE1
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
- Status
- COMPLETED
- Phase
- PHASE3